Top Japanese Stocks To Own Right Now

In the depths of the Great Recession, many people thought Whole Foods (NASDAQ: WFM  ) was done for. I didn’t agree with those folks, and I backed that assertion up two years ago — when I pledged  to buy $4,000 worth of Whole Foods stock for my retirement portfolio.

Over that time frame — especially given yesterday’s earnings beat — the stock has performed exceptionally well. My original investment is now worth $6,612, or $1,540 more than if I had invested in the SPDR S&P 500 ETF.

WFM Total Return Price data by YCharts.

Today, I’m going to spell out why Whole Foods remains as must-have holding for my retirement portfolio.

An undeniable trend
One of the most disturbing side effects of the industrial revolution is that people like you and me became completely disconnected from where we get our food. That oversight is now front and center in many Americans’ psyches — as diabetes and obesity rates reach alarming levels.

Top Japanese Stocks To Own Right Now: National Retail Properties (NNN)

National Retail Properties, Inc. is a publicly owned equity real estate investment trust. The firm acquires, owns, manages, and develops retail properties in the United States. It provides complete turn-key and built-to-suit development services including market analysis, site selection and acquisition, entitlements, permitting, and construction management. The firm also focuses on purchasing and financing net-leased retail properties. It was formerly known as Commercial Net Lease Realty, Inc. National Retail Properties was founded in August 1984 and is based in Orlando, Florida.

Advisors’ Opinion:

  • [By Dan Burrows]

    Here are the three dependable dividend stocks that are up at least 10% year-to-date, as of Feb. 11:

    Dependable Dividend Stocks: National Retail Properties (NNN)

    Dividend Yield: 4.9%
    YTD Gain: 10%

  • [By Charles Sizemore]

    ARCP has a shorter trading history than some of its peers, such as Realty Income (O) and National Retail Properties (NNN), which largely explains why its yield is higher. As a relatively new REIT, ARCP stock is largely unfollowed by investors. But once its merger with Cole Properties (COLE) is completed, ARCP will be the largest trip-net REIT by market cap and total square footage, and it will no longer be flying under Wall Street’s radar.

Top Japanese Stocks To Own Right Now: First Financial Corporation Indiana(THFF)

First Financial Corporation, through its subsidiaries, provides various financial services. Its deposit products include interest-bearing and non-interest-bearing demand deposits, savings accounts, time deposits, and certificates of deposit. The company?s loan portfolio comprises commercial, financial, and agricultural loans; residential loans; and consumer loans. It also provides mortgage lending; lease financing; trust account and depositor services; and insurance services, such as property and casualty insurance, surety bonds, employee benefit plans, life insurance, and annuities. The company operates 54 branches in west-central Indiana and east-central Illinois. First Financial Corporation was founded in 1984 and is headquartered in Terre Haute, Indiana.

Advisors’ Opinion:

  • [By Doug Hughes]

    Doug Hughes: Sure, there is another one. The next one, the symbol would be (THFF). They’re in Indiana, a very large bank. First Federal Financial Corporation. Again, their book value is $27.

  • [By James E. Brumley]

    What do Prospect Capital Corporation (NASDAQ:PSEC), Astec Industries, Inc. (NASDAQ:ASTE), and First Financial Corp. (NASDAQ:THFF) have in common? Not much, on the surface. In fact, were it not for something very specific to one particular person (me), they’d have nothing in common at all. This week though, THFF, ASTE, and PSEC all have at least one thing in common, and that’s the fact that they’re all going into my mental/hypothetical portfolio.

Top Japanese Stocks To Own Right Now: Tranzyme Inc.(TZYM)

Tranzyme, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of acute and chronic gastrointestinal (GI) motility disorders in the United States and internationally. The company?s clinical product candidates include ulimorelin, an intraveneous ghrelin agonist, which is in the Phase III clinical development stage for the treatment of acute upper GI motility disorders; and TZP-102, an orally-administered ghrelin agonist that has commenced Phase IIb clinical development stage for the treatment of diabetic gastroparesis. Its preclinical product candidates comprise TZP-201, a motilin antagonist for the treatment of various forms of moderate-to-severe diarrhea; and TZP-301, an oral ghrelin antagonist for the treatment of metabolic diseases. The company has strategic collaboration with Bristol-Myers Squibb Company to discover, develop, and commercialize additional novel co mpounds; and a license agreement with Norgine B.V to develop and commercialize ulimorelin in Europe, Australia, New Zealand, the Middle East, and north and South Africa. Tranzyme, Inc. was founded in 1998 and is headquartered in Durham, North Carolina.

Advisors’ Opinion:

  • [By CRWE]

    Tranzyme Pharma (Nasdaq:TZYM) reported that it has closed the previously announced underwritten registered direct offering of approximately 3.0 million shares of its common stock at a price of $3.85 per share for gross proceeds, including the over-allotment option, of approximately $11.5 million.

Top Japanese Stocks To Own Right Now: ICICI Bank Ltd (IBN)

ICICI Bank Limited (the Bank), incorporated on January 5, 1994, is a banking company. The Bank, together with its subsidiaries, joint ventures and associates, is a diversified financial services group providing a range of banking and financial services, including commercial banking, retail banking, project and corporate finance, working capital finance, insurance, venture capital and private equity, investment banking, broking and treasury products and services. It operates under four segments: retail banking, wholesale banking, treasury and other banking. Retail Banking includes exposures of the Bank, which satisfy the four criteria of orientation, product, granularity and low value of individual exposures for retail exposures. Wholesale Banking includes all advances to trusts, partnership firms, companies and statutory bodies, which are not included under Retail Banking. Treasury includes the entire investment portfolio of the Bank. Other Banking includes hire purchase a nd leasing operations and other items. As of March 31, 2012, the Bank had 17 subsidiaries. During the fiscal year ended March 31, 2013, the Company added 348 branches and 1,475 automated teller machines (ATMs) to its network, taking its branch and ATM count to 3,100 and 10,481 respectively at March 31, 2013.

Retail Banking

The branch network serves as an integrated channel for deposit mobilization, selected retail asset origination and distribution of third-party products, as well as the focal point for customer service. During fiscal 2011, the Bank continued its focus on increasing the proportion of low-cost retail deposits in its funding base. During fiscal 2011, its retail disbursements increased as it focused on opportunities in residential mortgages, vehicle finance and construction equipment finance. The Company also continued to focus on cross-selling new products and products of its life and general insurance subsidiaries to its existing cus tomers. As of March 31, 2013, its ATMs offer services such a! s opening fixed deposits, payment of credit card and utility bills, payment of insurance premium, mobile re-charges and ultra fast cash.

Small Enterprises

The Company offers banking solutions to small and medium enterprises across industry segments. The Company supports the growth of the small and medium enterprises sector while adopting a cluster-based financing approach for enterprises with a homogeneous profile in industries, such as infrastructure, engineering, information technology, education, life-sciences and agri-based businesses. The Company also offers supply chain financing solutions to the channel partners of large corporates.

Corporate Banking

The Bank offers a suite of corporate banking products, including rupee and foreign currency debt, working capital credit, structured financing, loan syndication and commercial banking products and services. The Company also puts in place product specific teams with a vi ew to focus on designing financial solutions for clients spread across structured finance, project finance, loan syndication and markets. The relationship team also works with its Markets Group to assist customers in devising and executing risk management strategies to address foreign currency, interest rate and liquidity risks. Its loan syndication franchise enables the Bank to structure, underwrite and syndicate rupee and foreign currency debt with Indian and offshore investors. The Bank has built robust sector-specific syndication skills across project finance, merger and acquisition (M&A) financing and structured finance to provide optimal financing solutions.

International Banking

The Company’s international banking business is focused on meeting the foreign currency needs of its Indian corporate clients and partnering them in their global expansion, taking select trade finance exposures linked to imports to India. ICICI Bank has subsidiaries in the United Kingdom, Russia and Canada, branches in the U! nited Sta! tes, Singapore, Bahrain, Hong Kong, Sri Lanka, Dubai International Finance Centre and Qatar Financial Centre and representative offices in the United Arab Emirates, China, South Africa, Bangladesh, Thailand, Malaysia and Indonesia. The Bank’s wholly owned subsidiary, ICICI Bank UK PLC, has 11 branches in the United Kingdom and a branch each in Belgium and Germany. ICICI Bank Canada has nine branches. ICICI Bank Eurasia Limited Liability Company has one branch.

The Company develops products and service offerings to meet the requirements of the Non Resident Indian (NRI) community. The Bank launched I-Express, an instant cross-border money transfer option for NRIs through its select partners in the Middle East. The I-Express facility offers the remitter an option of visiting any partner outlet for instant credit into the beneficiary account maintained with ICICI Bank in India, at no extra cost. The Company also launched Fixed Rupee on Money2India.com, a facility that enables NRIs to send the exact rupee amount remittance to India since the exchange rate is confirmed at the time of initiating the remittance.

Inclusive and Rural Banking

Inclusive and Rural Banking include offering credit to the rural market through the Bank’s branches and dedicated field teams and financial inclusion through business correspondents. The Bank focuses on improving its product and service offerings to meet the requirements of all participants in the rural market, including farmers, traders, commission agents, small processors and other medium agri-corporates. The Bank focuses on building capacity to implement its financial inclusion plan. The Bank also focused on opening accounts for routing benefit payments under various government schemes and has received the mandate for opening accounts of individuals under these schemes in certain states.

The Bank has also identified 25 business correspondents having a network of over 7,500 customer service points, to service these cust! omers. Th! e Bank provides basic financial services to the unbanked and underbanked

population comprising small and marginal farmers, daily wage labourers, beneficiaries of government. Around 47% of the Bank’s branches are in rural and semi-urban areas

Treasury

The Bank provides provide foreign exchange and derivative products and services to customers through its Markets Group. These products and services include foreign exchange products for hedging currency risk, foreign exchange and interest rate derivatives, such as options and swaps and bullion transactions.

Advisors’ Opinion:

  • [By Selena Maranjian]

    Finally, Caxton Associates’ biggest closed positions included Sprint Nextel and JPMorgan Chase. Other closed positions of interest include India-based ICICI Bank (NYSE: IBN  ) . In April, the bank reported double-digit profit increases and rising ROE. Analysts at Zacks downgraded the bank earlier this month, though, citing deterioration of its credit quality and expected steep operating expenses.

  • [By Selena Maranjian]

    Finally, Viking’s biggest closed positions included News Corp. and Schlumberger. Other closed positions of interest include India-based ICICI Bank (NYSE: IBN  ) . In April, the bank reported double-digit profit increases and rising ROE, and it recently yielded 2%. Analysts at Zacks downgraded the bank earlier this month, though, citing deterioration of its credit quality and expected steep operating expenses. ICICI is a major lender in India and is growing briskly there, and is expanding abroad, targeting even China. Its stock is up about 29% over the past year and has averaged 20.5% annually over the past decade.

  • [By Chuck Carnevale]

    ICICI Bank Limited-ADR (IBN)

    My second featured aggressive financial is ICICI Bank Limited-ADR (IBN), an ADR (American Depository Receipt) headquartered in India. This company is the largest private sector bank in India. Current low valuation is what most attracted me to this aggressive selection. However, I believe that prospective investors should carefully consider the amount of price volatility that has historically occurred with their share price. Nevertheless, for those dividend growth investors with a stomach for risk, this company may be worth taking a closer look at.

  • [By Anuchit Nguyen]

    Indian stocks declined, with the benchmark index halting a four-week rally, after central bank Governor Raghuram Rajan’s comment that inflation is still high. ICICI Bank (IBN) dropped to the lowest level since Sept. 5. The S&P BSE Bankex Index retreated 1.8 percent.

Top Japanese Stocks To Own Right Now: Fidelity National Information Services Inc (FIS)

Fidelity National Information Services, Inc. (FIS), incorporated on March 2, 2001, is a global provider of banking and payments technologies. The Company operates in four segments: Financial Solutions Group (FSG), Payment Solutions Group (PSG), International Solutions Group (ISG) and Corporate and Other Segment. The Company is engaged in payment processing and banking solutions, providing software, services and outsourcing of the technology. The Company offers financial institution core processing, card issuer and transaction processing services, including the NYCE Network, a national electronic funds transfer (EFT) network. FIS serves more than 14,000 institutions in over 100 countries. In February 2011, FIS acquired GIFTS Software, Inc., a provider of integrated funds transfer, Web-based cash management systems and anti-money laundering (AML) solutions. In April 2012, it acquired ICS Risk Advisors and Memento, Inc. In August 2012, the Company completed the sale of its He althcare Solutions business to an investment fund affiliated with Lightyear Capital LLC. In March 2013, it announced the acquisition of mFoundry.

Financial Solutions Group

FSG is to provide the software and services for the core processing, customer channel, treasury, cash management, wealth management and capital market operations of its financial institution customers in North America. The Company services the core and related ancillary processing needs of North American banks, credit unions, automotive financial companies, commercial lenders, and independent community and savings institutions. FIS offers a selection of in-house and outsourced solutions to banking customers that span the range of asset sizes. Its solutions in this segment include Core Processing and Ancillary Applications, Channel Solutions, Decision and Risk Management Solutions, Syndicated Loan Applications, Global Commercial Services and Strategic Consulting Services.

The Company’s processing software applications are de! signed to run banking processes for its financial institution clients, including deposit and lending systems, customer management, and other central management systems. The Company also offers a number of services that are ancillary to the primary applications listed above, including branch automation, back office support systems and compliance support. In addition, its wealth management services offer a set of Internet-enabled services to financial services providers that address the specific needs of markets, as well as commercial clients. These solutions address asset and liability aggregation, trust and investment account management, client and regulatory reporting, and employee retirement benefit services. The Company also offers an application suite that assists automotive finance institutions in evaluating loan applications and credit risk, and allows automotive finance institutions to manage their loan and lease portfolios.

The Company’s suite of retai l delivery applications enables financial institutions to integrate customer-facing operations and back-office processes, thereby improving customer interaction across all channels (branch offices, Internet, automated teller machine (ATM), call centers). Its Consumer Electronic Banking and Business Internet Banking both provide a set of cash management capabilities, enabling customers to manage banking and payments through the Internet, mobile devices, accounting software and telephone. Corporate Electronic Banking solutions provide commercial treasury capabilities, including cash management services and multi-bank collection and disbursement services that address the specialized needs of corporate customers. FIS systems provide accounting and reconciliation for such transactions, serving as the system of record and providing regulatory compliance, risk assessment and fraud management tools.

The Company’s decision solutions offers a spectrum of options that co ver the account lifecycle from helping to identify qualified! account ! applicants to managing mature customer accounts and fraud. Its applications include know-your-customer, new account decisioning, new account opening, account and transaction management, fraud management and collections. Its risk management services utilize its risk management models and data sources to assist in detecting fraud and assessing the risk of opening a new account or accepting a check at either the point-of-sale, a physical branch location, or through the Internet. Its systems utilize a combination of advanced authentication procedures, predictive analytics, artificial intelligence modeling and shared databases to assess and detect fraud risk for deposit transactions for financial institutions.

The Company’s syndicated loan applications are designed to support wholesale and commercial banking requirements necessary for all aspects of syndicated commercial loan origination and management. Its global commercial services include solutions, both onshore and offshore, designed to meet the technology challenges facing principally Unites States based clients, large or small. Its technology solutions range in scope from consulting engagements to application development projects and from operations support for a single application to management of information technology infrastructures. The Company also provides outsourcing teams todeliver customer service. With the The Capital Markets Company NV (Capco) acquisition, it provides integrated consulting, technology and transformation services. Capco specializes in banking; capital markets; wealth and investment management; finance, risk and compliance, and technology. Capco’s North American operations are included in FSG.

Payment Solutions Group

PSG provides a set of software and services for the EFT, card processing, item processing, bill payment, and government and healthcare payments processing needs of its customers in North America. PSG is focused on servicing the payment and electronic funds transfer needs o! f North A! merican headquartered banks and credit unions, commercial lenders, independent community and savings institutions and healthcare and government institutions. Its solutions in this segment include Electronic Funds Transfer, Item Processing and Output Services, Credit Card Solutions, Government and Healthcare Payments Solutions, ePayment Solutions and Check Authorization.

The Company’s electronic funds transfer and debit card processing businesses offer settlement and card management solutions for financial institution card issuers. It provides traditional ATM- and personal identification number (PIN)-based debit network access and emerging real-time payment alternatives through NYCE. It is also a provider of prepaid card services, which include gift cards and reloadable cards, with end-to-end solutions for development, processing and administration of stored-value programs.

The Company’s item processing services furnish financial institutions wi th the equipment needed to capture data from checks, transaction tickets and other items; image and sort items; process exceptions through keying, and perform balancing, archiving and the production of statements. Its item processing services are utilized by more than 1,500 financial institutions. Its solutions include distributed ( non-centralized) data capture, check and remittance processing, fraud detection, and document and report management. Its Endpoint Exchange Network enables United States financial institutions to clear their check-based transactions by allowing for the exchange of check images between member institutions. The Company offers a number of output services that are ancillary to the primary solutions it provide, including print and mail capabilities and card personalization fulfillment services. Its CSF Designer document composition software is used by many clients in various industries to furnish printed or electronically produced invoices and statemen ts for customized customer communication. Its print and mail! services! offers computer output solutions for the creation, management and delivery of print and fulfillment needs. The Company provides its card personalization fulfillment services for branded credit cards and branded and non-branded debit and prepaid cards. More than 5,200 financial institutions utilize a combination of its technology and/or services to issue VISA, MasterCard or American Express branded credit and debit cards or other electronic payment cards for use by both consumer and business accounts. Its services range from card production and activation to a range of fraud management services to value-added loyalty programs designed to increase card usage and fee-based revenues.

FIS healthcare payments solutions facilitate the exchange of information and funds among patients, payers, providers and financial institutions. With Web-enabled tools, a Health Savings Account (HSA) platform, multi-purse benefit debit cards that cover multiple spending accounts with a single card and combined eligibility/payment cards, FIS enables consumers and third-party benefits administrators to have integrated benefit account management of HSAs, Flexible Spending Accounts (FSA), Health Reimbursement Agreements (HRA) and dependent care and transportation accounts. It also provides customized electronic service applications for government agencies, including Internal Revenue Service (IRS) payment services. It also facilitates the collection of state income taxes, real estate taxes, utility bills, vehicle registration fees, driver’s license renewal fees, parking tickets, traffic citations, tuition payments, court fees and fines, hunting and fishing license fees, as well as various business licenses.

The Company provides bill publishing and bill consolidation technology for its customers, generating millions of monthly bills and servicing both billers and financial institution customers. Online bill payment functionality includes credit a nd debit card-based expedited payments. Its end-to-end prese! ntment an! d payment solution provides an all-in-one solution to meet billers’ needs for the distribution and collection of bills and other customer documents. FIS also provides automated clearing house (ACH) processing. Its check authorization business provides check risk management and related services to businesses accepting or cashing checks. Its services assess the likelihood (and often provide a guarantee) that a check will clear.

International Solutions Group

The Company provides core banking applications, channel solutions, card and merchant services, item processing and check risk management solutions to financial institutions, card issuers and retailers. Its international operations leverage existing applications and provide services for the specific business needs of its customers in targeted international markets. Services are delivered from 28 operations centers around the world. Its payment solutions services include outsourced card-issuer ser vices and customer support, payment processing and switching services, prepaid and debit card processing, item processing, software licensing and maintenance, outsourced ATM management and retail point-of-sale check warranty services. Its financial solutions services include fully outsourced core bank processing arrangements, application management, software licensing and maintenance, facilities management and consulting services, including Capco’s international operations.

Corporate and Other Segment

The Corporate and Other segment consists of the corporate overhead costs that are not allocated to operating segments. These include costs related to human resources, finance, legal, accounting, domestic sales and marketing, merger and acquisition activity and amortization of acquisition-related intangibles and other costs that are not considered when management evaluates operating segment performance.

The Company competes with Fiserv, Inc ., Jack Henry and Associates, Inc., Open Solutions, Inc., In! ternation! al Business Machines Corporation (IBM), Accenture Ltd., Alliance Data Systems Corporation, DST Systems, Harland Financial Solutions, Inc., SEI Investments Company, S1Corporation, SunGard Data Systems, Inc., Alnova Technologies Corporation, Oracle Financial Services Software Limited, Misys plc, Infosys Technologies Limited, Temenos Group AG, MasterCard Incorporated, Visa Inc., First Data Corporation, Total System Services, Inc., HP Enterprise Services, Payment Systems for Credit Unions (PSCU), Heartland Payments Systems, Inc. and Global Payments, Inc.

Advisors’ Opinion:

  • [By Marc Bastow]

    Banking and payments services and support company Fidelity National Information Services (FIS) raised its quarterly dividend 9% to 24 cents per share, payable on Mar. 31 to shareholders of record as of Mar. 17.
    FIS Dividend Yield: 1.90%

Top Japanese Stocks To Own Right Now: EDAP TMS S.A.(EDAP)

EDAP TMS S.A., through its subsidiaries, engages in the development, manufacture, and marketing of minimally invasive medical devices primarily for urological diseases. The company operates in two divisions, High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS). The HIFU division involves in the development, manufacture, and marketing of medical devices based on HIFU technology for the minimally invasive destruction of various types of localized tumors. This division offers Ablatherm, a HIFU-based ultrasound guided device for the treatment of organ-confined prostate cancer. Its HIFU technology allows the surgeon to destroy a defined area of diseased tissue without damaging surrounding tissue and organs. This division also engages in the leasing of equipment, as well as the sale of disposables, spare parts, and maintenance services. This division markets and sells its products through its direct marketing and sales organization, as well as through third-party distributors and agents. The UDS division engages in the development, manufacture, marketing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, primarily urinary stones and other clinical indications. This division provides lithotripters for the treatment of urinary tract stones by means of ESWL technology. This division manufactures three models of lithotripters: the Sonolith Praktis, the Sonolith i-move, and the Sonolith i-sys. This division also involves in the leasing of lithotripters, as well as the sale of disposables, spare parts, and maintenance services. This division markets and sells its products through its direct sales and service platform, as well as through agents and third-party distributors. The company?s customers include public and private hospitals, urology clinics, and research institutions worldwide. EDAP TMS S.A. was founded in 1979 and is based in Vaulx-en-Velin, France.

Advisors’ Opinion:

  • [By John Udovich]

    Laparoscopic surgery or minimally invasive surgery (MIS) is a type of surgical technique where operations in the abdomen are performed through small incisions while small cap stocks ArthroCare Corporation (NASDAQ: ARTC), EDAP TMS S.A. (NASDAQ: EDAP), SafeStitch Medical Inc (OTCBB: SFES) and Arch Therapeutics Inc (OTCBB: ARTH) are all in some way focused on aiding minimally invasive procedures. According to a 2012 report produced by MedMarket Diligence, LLC, approximately 114 million surgical and procedure-based wounds occur annually worldwide, including 36 million in the US, and perhaps up to a quarter of these procedures can be described as laparoscopic in nature. Moreover, use of the technique is bound to increase as it reduces pain and hemorrhaging plus leads to a shorter recovery time.

Top Japanese Stocks To Own Right Now: Mazda Motor Corp (MZDAY.PK)

Mazda Motor Corporation is a Japan-based company engaged in the manufacture and distribution of automobiles and automobile parts. The Company provides mini vans, compact vehicles, sports cars, sport-utility vehicles, station wagons, sedans, light cars, commercial vehicles, welfare vehicles and special edition automobiles, as well as automobile accessories, including car navigation systems, automobile audio systems, side monitors, rear seat monitors, electronic toll collection (ETC) in-vehicle equipment, security products, driving support products, bulbs, pet carriers and child seats, among others. As of March 31, 2013, the Company had 56 consolidated subsidiaries and 15 associated companies. Advisors’ Opinion:

  • [By Elliott Gue]

    This so-called One Ford initiative involved the US$2.3 billion sale of Jaguar and Land Rover to Tata Motors (TTM) and the US$1.6 billion divestment of Volvo to Geely Automobile Holdings (GELYF.PK). After selling the majority of its stake in Mazda Motor Corp (MZDAY.PK) and discontinuing Mercury, Ford Motor Company’s portfolio consists of its eponymous mass-market brand and the higher-end Lincoln.

Top Japanese Stocks To Own Right Now: Zurich Insurance Group AG (ZURN)

Zurich Insurance Group Limited is a Switzerland-based holding company engaged in the insurance sector. The Company provides a range of general and life insurance products and services for individuals, small business, mid-sized and large-sized companies, and multinational corporations. The Company offers its products and services through three business segments, namely General Insurance, Global life and Farmers. The General Insurance segment offers motor, home and commercial products and services for individuals, as well as small and large business. The Global life segment offers life insurance, savings, investment and pensions solutions. The Farmers segment includes farmers management services, which provides non-claims management services to the farmers exchange, as well as Farmers Re business, which includes reinsurance assumed from the Farmers Exchange by the Company’s group. Furthermore, the Company provides reinsurance and insurance business considered as non-core busine ss. Advisors’ Opinion:

  • [By Namitha Jagadeesh]

    Zurich Insurance Group AG (ZURN) lost 3.6 percent after second-quarter profit missed analysts’ estimates. Hennes & Mauritz AB (HMB) declined the most in seven weeks as Europe’s second-biggest clothing retailer reported worse-than-expected sales. BG Group Plc, which derives 20 percent of its oil-and-gas production from Egypt, slipped 2.4 percent as the death toll from nationwide violence in the most populous Arab country climbed above 500.

Top Japanese Stocks To Own Right Now: Coronado Biosciences Inc (CNDO)

Coronado Biosciences, Inc., incorporated on June 28, 2006, is a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer. The Company’s two principal pharmaceutical product candidates in clinical development include Trichuris suis ova or CNDO-201 (TSO) a biologic comprising of the microscopic eggs of the porcine whipworm, for the treatment of autoimmune diseases, such as Crohn’s disease (Crohn’s), ulcerative colitis (UC) and multiple sclerosis (MS), and CNDO-109, a compound that activates natural killer (NK) cells of the immune system to seek and destroy cancer cells, for the treatment of acute myeloid leukemia (AML). In January 2011, the Company acquired the OvaMed GmbH License.

TSO

TSO is the microscopic eggs of a parasitic helminth, or worm, that is found in pigs. In September 2011, the Company filed an Investigational New Drug Application (IND) with t he United States Food and Drug Administration (FDA) and it initiated a single dose, dose escalation study in patients with Crohn’s in February 2012. The Phase 1 clinical trial was a multi-center, sequential dose-escalation, double-blind, placebo-controlled study, the primary objective of which was to evaluate the safety and tolerability of TSO. The trial enrolled 36 patients with Crohn’s ranging in age from 20 to 54 with an equal distribution of male and female patients in three single dose cohorts of orally administered 500, 2500 and 7500 ova. Each cohort had 12 patients, with nine patients receiving TSO and three receiving placebo.

CNDO-109

CNDO-109 is a lysate (disrupted CTV-1 cells, cell membrane fragments, cell proteins and other cellular components) that activates donor NK cells. CTV-1 is a leukemic cell line recently re-classified as a T-cell acute lymphocytic leukemia (ALL). The Company has worldwide rights to develop and commercialize CNDO-109 activated NK cells for the treatment of cancer fro! m UCLB. In February 2012, the Company submitted an IND for the CNDO-109 activated NK cell product in the United States. The treatment of patients with CNDO-109 activated NK cells involves several steps. The activated NK cells are infused into the patient after resting NK cells are incubated with CNDO-109 for at least eight hours. Preparation of CNDO-109 activated NK cells takes about 24 hours from start to finish.

The Company competes with Centocor Ortho Biotech Inc.’s Remicade , UCB S.A.’s Cimzia, Abbott Laboratories’ Humira, Biogen Idec’s Avonex, Bayer Healthcare Pharmaceuticals’ Betaseron, Teva Pharmaceuticals Industries, Ltd.’s Copaxone and Novartis AG’s Gilenya.

Advisors’ Opinion:

  • [By Roberto Pedone]

    One under-$10 biopharmaceutical player that’s quickly moving within range of triggering a major breakout trade is Coronado Biosciences (CNDO), which is focused on novel immunotherapy biologic agents for autoimmune diseases and cancer. This stock has been hit hard by the bears in 2013, with shares off by 43%.

    If you take a look at the chart for Coronado Biosciences, you’ll notice that this stock has been uptrending strong since it double bottomed in November, with shares moving higher from its low of $1.25 to its intraday high of $2.58 a share. During that uptrend, shares of CNDO have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of CNDO within range of triggering a major breakout trade.

    Traders should now look for long-biased trades in CNDO if it manages to break out above some key overhead resistance at $2.70 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 1.97 million shares. If that breakout hits soon, then CNDO will set up to re-fill some of its previous gap down zone from October that started near $7 a share. Some possible upside targets if CNDO gets into that gap with volume are $4 to $5 a share.

    Traders can look to buy CNDO off any weakness to anticipate that breakout and simply use a stop that sits right around some key near-term support at $2 a share. One can also buy CNDO off strength once it takes out $2.70 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.

  • [By Ben Fox Rubin]

    Biopharmaceutical firm Coronado Biosciences Inc.(CNDO) said a recent pilot study found that the first five patients using its potential autism treatment showed statistically significant separation from placebo, in favor of the drug. The treatment was also well-tolerated. The study is still ongoing. Shares jumped 26% to $2.25 premarket.

  • [By James E. Brumley]

    The last few weeks haven’t been particularly encouraging for Crohn’s disease sufferers. In August, GlaxoSmithKline (NYSE: GSK) and ChemoCentryx (NASDAQ:CCXI) reported that a jointly-developed Crohn’s drug, vercirnon, had failed to meet its late-stage trial endpoints. Though the in-development drug isn’t dead in the water (GSK and CCXI could rework the drug, the testing regimen, or use it for other indications), it doesn’t look good. Then this month – just a few days ago – Coronado Biosciences Inc. (NASDAQ:CNDO) reported that its Phase 3 trials of Crohn’s disease drug TSO had also failed to meet its primary endpoints as well. Like vercirnon, CNDO isn’t completely out of luck here with the treatment, but forging ahead with further development of the treatment is grasping at straws. Crohn’s sufferers don’t need to give up home just yet, however – TNI Biotech Inc. (OTCMKTS:TNIB) appears to have a Crohn’s treatment that works, and should be able to sidestep the problems that pl agued ChemoCentryx, GlaxoSmithKline, and Coronado Biosciences.

  • [By Brian Pacampara]

    Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool’s free investing community, biotechnology company Coronado Biosciences (NASDAQ: CNDO  ) has received a distressing two-star ranking.